This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Recursion Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: David Evans: Innovator in MALT-1 Modulation
Introduction: David Evans is a prominent inventor based in Oxford, GB. He has made significant contributions to the field of medical research, particularly in the modulation of MALT-1. His innovative work has the potential to impact the treatment of various diseases and conditions.
Latest Patents: David Evans holds a patent for MALT-1 modulators. This patent discloses compounds, compositions, and methods for treating diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT-1. The compounds are represented by specific formulas, wherein the variables are defined in the patent documentation. He has 1 patent to his name.
Career Highlights: David is currently employed at Recursion Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work focuses on creating innovative solutions for complex medical challenges.
Collaborations: David has collaborated with notable colleagues, including Peter Ray and Anthony Bradley. These partnerships enhance the research environment and foster innovation in their projects.
Conclusion: David Evans is a dedicated inventor whose work in MALT-1 modulation holds promise for future medical advancements. His contributions to the field exemplify the impact of innovative research on healthcare.